SynCo Pharma B.V. secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Filgrastim ATC L03AA02 for the period 01042024 - 31032026

Germany, June 18 -- Germany based SynCo Pharma B.V. has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Filgrastim ATC L03AA02 for the period 01042024 - 31032026 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....